MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Steris profits dive as product shipments slow
Steris Corp. (NYSE:STE) posted net income of $21.8 million, or 36 cents per diluted share, on sales of $328.3 million during the three months ended Dec. 31. That compares with net income of $41.0 million, or 69 cents per diluted share, on sales of $327.8 million during the same period last year. The Mentor, Ohio-based company has struggled to replace lost revenue from its recalled System 1 sterilization device.
Read more
Owens & Minor sales rise but, profits dip
Owens & Minor Inc. (NYSE:OMI) reported net income of $21.8 million, or 34 cents per diluted share, on revenue of $2.07 billion during the three months ended Dec. 31. That compares with a profit of $32.3 million, or 51 cents per diluted share, on revenue of $2.04 billion during the same period last year. The company on Feb. 7 announced a 13 percent increase in dividend for its first quarter 2011 and a $50 million share repurchase program.
Read more
Luminex sales get an 8 percent bump
Luminex Corp. (NYSE:LMNX) reported profits of $3.2 million, or 7 cents per diluted share, on sales of $41.2 million during the three months ended Dec. 31. That compares with profits of $20.0 million, or 48 cents per diluted share, on sales of $38.2 million during the same period last year.
Read more
Genomic Health rises out of the red on 19 percent revenue increase
Genomic Health Inc. (NSDQ:GHDX) reported net income of $1.7 million or 6 cents per diluted share, on sales of $47.1 million during the three months ended Dec. 31. That compares with a loss of about $341,000, or 1 cent per diluted share, on sales of $39.6 million during the same period last year.
Read more
Illumina profits more than triple after sales increase 45 percent
Illumina Inc. (NSDQ:ILMN) recorded a profit of $38.4 million, or 25 cents per diluted share, on sales of $261.3 million during the three months ended Dec. 31. That compares with a profit of $11.7 million, or 9 cents per diluted share, on sales of $180.6 million during the same period last year.
Read more
